PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS

DEFINITIVE CONTRACT won by MINISTRY OF DEFENCE
$694,901
RecipientMINISTRY OF DEFENCE UEI U6LDUQKZ2CS8
Award IDHDTRA120C0016
Award amount$694,901
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Defense Threat Reduction Agency
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAD93
Start dateJun 15, 2020
End dateSep 14, 2023
Place of performance—
Record updatedAug 18, 2022

View the official award record

More awards won by MINISTRY OF DEFENCE

PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A AND B
Department of Health and Human Services · $146,300,000 · Jul 15, 2024
CWB KITS & SHIPPING FIXTURE
Department of Defense · $9,139,900 · Sep 17, 2024
BASE PERIOD IGF::OT::IGF
Department of Defense · $4,402,389 · Oct 31, 2016
GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.
Department of Defense · $4,346,947 · Jun 10, 2024
NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS
Department of Defense · $3,498,014 · Sep 28, 2022

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids